There is also evidence that FIV can establish a latent infection in vivo following mucosal administration of low-dose cell-associated FIV-A [89], in peripheral blood CD4+ T-cells during chronic FIV-C infection [10], and in peripheral blood mononuclear cells (PBMC) during chronic FIV-B infection [90]. This evidence concerns the gene CD4 and infection.